Literature DB >> 16869772

How do cancer cells acquire the fuel needed to support cell growth?

C B Thompson1, D E Bauer, J J Lum, G Hatzivassiliou, W-X Zong, F Zhao, D Ditsworth, M Buzzai, T Lindsten.   

Abstract

In this paper we consider whether the dependency of metazoan cells on extracellular signals to maintain cell survival results in an important barrier that must be overcome during carcinogenesis. It is now generally accepted that a major barrier to cancer comes from the inability of cells to enter and progress through the cell cycle in a cell-autonomous fashion. Most of the oncogenes studied over the last two decades contribute to the ability of the cancer cell to enter and progress through the cell cycle in the absence of the instructional signals normally imparted by extracellular growth factors. Over the last two decades, it has begun to be appreciated that there is a second potential barrier to transformation. It appears that all cells in multicellular organisms need extracellular signals not only to initiate proliferation, but also to maintain cell survival. Every cell in our body expresses the proteins necessary to execute its own death by apoptosis. A cell will activate this apoptotic program by default unless it receives signals from the extracellular environment that allow the cell to suppress the apoptotic machinery it expresses. It now appears that the molecular basis of this suppression lies in the signaling pathways that regulate cellular nutrient uptake and direct the metabolic fate of those nutrients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16869772     DOI: 10.1101/sqb.2005.70.011

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  11 in total

Review 1.  Metabolic catastrophe as a means to cancer cell death.

Authors:  Shengkan Jin; Robert S DiPaola; Robin Mathew; Eileen White
Journal:  J Cell Sci       Date:  2007-02-01       Impact factor: 5.285

2.  PEG-PHB-glutaminase nanoparticle inhibits cancer cell proliferation in vitro through glutamine deprivation.

Authors:  Sureshbabu Ram Kumar Pandian; Venkataraman Deepak; Hariharan Nellaiah; Krishnan Sundar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-26       Impact factor: 2.416

3.  Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer.

Authors:  Jennifer M Specht; Brenda F Kurland; Susan K Montgomery; Lisa K Dunnwald; Robert K Doot; Julie R Gralow; Georgina K Ellis; Hannah M Linden; Robert B Livingston; Kimberly H Allison; Erin K Schubert; David A Mankoff
Journal:  Clin Cancer Res       Date:  2010-05-11       Impact factor: 12.531

4.  Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression.

Authors:  Yuanyuan Li; Liang Liu; Trygve O Tollefsbol
Journal:  FASEB J       Date:  2009-12-17       Impact factor: 5.191

5.  Blood flow-metabolism mismatch: good for the tumor, bad for the patient.

Authors:  David A Mankoff; Lisa K Dunnwald; Savannah C Partridge; Jennifer M Specht
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

6.  Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation.

Authors:  Samira Alliouachene; Robyn L Tuttle; Stephanie Boumard; Thomas Lapointe; Sophie Berissi; Stephane Germain; Francis Jaubert; David Tosh; Morris J Birnbaum; Mario Pende
Journal:  J Clin Invest       Date:  2008-10-09       Impact factor: 14.808

Review 7.  Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies.

Authors:  Liem Minh Phan; Sai-Ching Jim Yeung; Mong-Hong Lee
Journal:  Cancer Biol Med       Date:  2014-03       Impact factor: 4.248

8.  An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).

Authors:  Salvador Harguindey; Gorka Orive; Ramón Cacabelos; Enrique Meléndez Hevia; Ramón Díaz de Otazu; Jose Luis Arranz; Eduardo Anitua
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

Review 9.  HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation.

Authors:  John D Gordan; Craig B Thompson; M Celeste Simon
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

10.  Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells.

Authors:  Mariia Yuneva; Nicola Zamboni; Peter Oefner; Ravi Sachidanandam; Yuri Lazebnik
Journal:  J Cell Biol       Date:  2007-07-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.